Evaluation of the different ESWL session intervals on acute kidney injury using urinary NGAL and KIM-1
DOI:
https://doi.org/10.5489/cuaj.9750Keywords:
urolithiasis., ESWL, NGAL, Kidney Injury Marker, eGFRAbstract
Introduction: We aimed to compare two different extracorporeal shockwave lithotripsy (ESWL) session intervals in terms of morbidity, clinical outcomes, and procedural safety, based on biomarkers used to detect acute kidney injury (AKI).
Methods: Patients were randomized into two groups prior to ESWL. In group 1, ESWL sessions were performed on days 0, 4, and 8, whereas in group 2, sessions were performed on days 0, 7, and 14. Urine samples were collected using the midstream technique and centrifuged at 3500 rpm for four minutes on the same day, then stored at -80°C. Kidney injury molecule-1 (KIM-1) and neutrophil gelatinase-associated lipocalin (NGAL) levels were measured using the ELISA method from urine samples obtained before the procedure and after three ESWL sessions.
Results: A total of 51 patients were included (group 1: n=25; group 2: n=26), with a median age of 45 years; 64.7% were male. Baseline demographic characteristics, comorbidities, and stone-related parameters were comparable between the groups. Preprocedural GFR and KIM-1 levels were similar; however, baseline NGAL levels were significantly higher in group 1 (p=0.009). Postprocedural GFR, NGAL, and KIM-1 levels did not differ significantly between the groups. Likewise, the changes in biomarkers and GFR were comparable between groups. In addition, complications and stone-free rates were similar between the groups.
Conclusions: Shorter ESWL session intervals were not associated with increased AKI. These findings suggest that there is no difference in safety between shorter and longer treatment intervals, and that the choice should be determined by the clinician based on practicality and feasibility.
Downloads
Downloads
Published
How to Cite
Issue
Section
License
You, the Author(s), assign your copyright in and to the Article to the Canadian Urological Association. This means that you may not, without the prior written permission of the CUA:
- Post the Article on any Web site
- Translate or authorize a translation of the Article
- Copy or otherwise reproduce the Article, in any format, beyond what is permitted under Canadian copyright law, or authorize others to do so
- Copy or otherwise reproduce portions of the Article, including tables and figures, beyond what is permitted under Canadian copyright law, or authorize others to do so.
The CUA encourages use for non-commercial educational purposes and will not unreasonably deny any such permission request.
You retain your moral rights in and to the Article. This means that the CUA may not assert its copyright in such a way that would negatively reflect on your reputation or your right to be associated with the Article.
The CUA also requires you to warrant the following:
- That you are the Author(s) and sole owner(s), that the Article is original and unpublished and that you have not previously assigned copyright or granted a licence to any other third party;
- That all individuals who have made a substantive contribution to the article are acknowledged;
- That the Article does not infringe any proprietary right of any third party and that you have received the permissions necessary to include the work of others in the Article; and
- That the Article does not libel or violate the privacy rights of any third party.




